This content is from: Premium Maverick’s Huge April Comeback How four stocks played an outsize role in the Tiger Cub’s big first quarter losses — and how they fared during April’s sharp rebound. By Stephen Taub May 11, 2020
This content is from: Portfolio The Morning Brief: Glenview Pressures Dow Chemical, DuPont The hedge fund reportedly is urging the chemical giants to change their plan to break the newly merged company into three parts. By Stephen Taub June 29, 2017
This content is from: Portfolio Hedge Fund Activists Pivot to ESG A handful of “name-brand” activists, including Trian Partners and ValueAct, have started taking on environmental and social issues at public companies, according to Cerulli. By Amy Whyte January 23, 2020
This content is from: Premium Greenlight’s Funds Fall Sharply in August The performance would have been even worse if not for strong gains in the hedge fund firm’s short book. By Stephen Taub September 03, 2019
This content is from: Portfolio Book Excerpt: DuPont and the New M&A When DuPont made a white knight bid for Conoco in 1981, it found itself mired in the realities of the new M&A. The company was never the same. By Robert Teitelman April 19, 2016
This content is from: Premium Equities Giveth, but Credit Taketh Away for Third Point The multistrategy fund headed by Dan Loeb generated offsetting results in its equity and credit books last month. By Stephen Taub September 04, 2019
Sponsored Material Winners and Losers in ESG Strategies A renowned quant shop rolls out an absolute return innovation that isn’t just long-only. Sponsored by CFM June 30, 2020
